Paul Sax, MD

Clinical Director, Professor of Medicine
Brigham and Women’s Hospital, Harvard Medical School

Disclosure: Gilead (Consultant, Research Grant or Support)Janssen (Consultant)Merck (Consultant, Research Grant or Support)ViiV Healthcare (Consultant, Research Grant or Support)

Presentation(s):

• LB-7 - Weight Change in Suppressed People with HIV (PWH) Switched from Either Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) to Tenofovir Alafenamide (TAF)

  Saturday, October 24, 2020
  10:50am – 11:00am EDT